CoChat

Diagnostic utility of transcriptome sequencing for rare Mendelian diseases

Open access
Lee, Hane, Huang, Alden Y., Wang, Lee-kai, Yoon, Amanda J., Renteria, Genecee, Eskin, Ascia, Signer, Rebecca H., Dorrani, Naghmeh, Nieves-Rodriguez, Shirley, Wan, Jijun, Douine, Emilie D., Woods, Jeremy D., Dell’Angelica, Esteban C., Fogel, Brent L., Martin, Martin G., Butte, Manish J., Parker, Neil H., Wang, Richard T., Shieh, Perry B., Wong, Derek A., Gallant, Natalie, Singh, Kathryn E., Tavyev Asher, Y. Jane, Sinsheimer, Janet S., Krakow, Deborah, Loo, Sandra K., Allard, Patrick, Papp, Jeanette C., Palmer, Christina, Martinez-Agosto, Julian A., Nelson, Stanley F. · 2020 · Genetics in Medicine
Cited by 224

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

We investigated the value of transcriptome sequencing (RNAseq) in ascertaining the consequence of DNA variants on RNA transcripts to improve the diagnostic rate from exome or genome sequencing for undiagnosed Mendelian diseases spanning a wide spectrum of clinical indications. From 234 subjects referred to the Undiagnosed Diseases Network, University of California–Los Angeles clinical site between July 2014 and August 2018, 113 were enrolled for high likelihood of having rare undiagnosed, suspected genetic conditions despite thorough prior clinical evaluation. Exome or genome sequencing and RNAseq were performed, and RNAseq data was integrated with genome sequencing data for DNA variant interpretation genome-wide. The molecular diagnostic rate by exome or genome sequencing was 31%. Integration of RNAseq with genome sequencing resulted in an additional seven cases with clear diagnosis of a known genetic disease. Thus, the overall molecular diagnostic rate was 38%, and 18% of all genetic diagnoses returned required RNAseq to determine variant causality. In this rare disease cohort with a wide spectrum of undiagnosed, suspected genetic conditions, RNAseq analysis increased the molecular diagnostic rate above that possible with genome sequencing analysis alone even without availability of the most appropriate tissue type to assess.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41436-019-0672-1

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 224

Metadata

Authors
Lee, H., Huang, A. Y., Wang, L.-K., Yoon, A. J., Renteria, G., Eskin, A., Signer, R. H., Dorrani, N., Nieves-Rodriguez, S., Wan, J., Douine, E. D., Woods, J. D., Dell’Angelica, E. C., Fogel, B. L., Martin, M. G., Butte, M. J., Parker, N. H., Wang, R. T., Shieh, P. B., Wong, D. A., Gallant, N., Singh, K. E., Tavyev Asher, Y. J., Sinsheimer, J. S., Krakow, D., Loo, S. K., Allard, P., Papp, J. C., Palmer, C., Martinez-Agosto, J. A., & Nelson, S. F.
Venue
Genetics in Medicine
Publisher
Elsevier BV
Published
2020-03
Volume
22
Issue
3
Pages
490-499
ISSN
1098-3600 (ISSN-L)
OpenAlex
W2979935292
Cited by
224
References
12
FWCI
12.32
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diagnostic utility of transcriptome sequencing for rare Mendelian diseases. https://app.cochat.ai/papers/10.1038/s41436-019-0672-1
The paper
Lee, H., Huang, A. Y., Wang, L.-K., Yoon, A. J., Renteria, G., Eskin, A., Signer, R. H., Dorrani, N., Nieves-Rodriguez, S., Wan, J., Douine, E. D., Woods, J. D., Dell’Angelica, E. C., Fogel, B. L., Martin, M. G., Butte, M. J., Parker, N. H., Wang, R. T., Shieh, P. B., . . . Nelson, S. F. (2020). Diagnostic utility of transcriptome sequencing for rare Mendelian diseases. Genetics in Medicine. https://doi.org/10.1038/s41436-019-0672-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.